SCHEMBL23965875

SCHEMBL23965875

C[C@@H]1CN(C(=O)N2CCn3cc(C4=C(c5cnc6ccccn56)C(=O)NC4=O)c4cc(F)cc(c43)C2)CCN1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 20/20 0.79
GSK3A P49840 14/20 0.79
PRKCB P05771 6/20 0.79
CDK4 P11802 6/20 0.79
CDK2 P24941 5/20 0.79
CAMK2G Q13555 3/20 0.79
CAMK2D Q13557 3/20 0.79
CDK5 Q00535 3/20 0.79
PDK1 Q15118 3/20 0.79
PRKCG P05129 2/20 0.79
LCK P06239 2/20 0.79
CDK1 P06493 2/20 0.79
PIM1 P11309 2/20 0.79
CLK2 P49760 2/20 0.79
RPS6KA3 P51812 2/20 0.79
PRKCD Q05655 2/20 0.79
DYRK1A Q13627 2/20 0.79
PKN2 Q16513 2/20 0.79
SLK Q9H2G2 2/20 0.79
CLK4 Q9HAZ1 2/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ly-2090314 SCHEMBL29533963 0.88 GSK3B (1.00) GSK3BGSK3APRKCBCDK4CDK2
Ly-2090314 SCHEMBL633455 0.88 GSK3B (1.00) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577693 0.88 GSK3B (0.79) GSK3BGSK3APRKCBCDK4CDK2
Ly-2090314 SCHEMBL635424 0.87 GSK3B (0.98) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577594 0.87 GSK3B (0.82) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577608 0.87 GSK3B (0.80) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577649 0.87 GSK3B (0.84) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577647 0.87 GSK3B (0.86) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577715 0.87 GSK3B (0.84) GSK3BGSK3APRKCBCDK4CDK2
SCHEMBL21577611 0.86 GSK3B (0.81) GSK3BGSK3APRKCBCDK4CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11162071-B2 Compositions and methods for generating hair cells by upregulating JAG-1 Frequency Therapeutics, Inc. (US) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11162071-B2 Compositions and methods for generating hair cells by upregulating JAG-1 NOTCH1, HES1, NOTCH3 GSK3B 1102/4885GSK3A 1348/4885PRKCB 197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.